[button : interested : interested : CM170]
Carnosine has been studied in relation to various neurodegenerative diseases, including dementia, Parkinson’s disease, and Alzheimer’s disease. However, it is important to note that research in this area is still ongoing and is not yet sufficient for definitive conclusions.
In terms of dementia, some studies suggest that carnosine could have a protective effect on the brain and could be associated with better cognitive status in people with dementia. For example, it has been found that carnosine can inhibit the formation of beta-amyloid, which is a hallmark of Alzheimer’s disease. However, further studies need to be conducted to assess the exact mechanisms and effects of carnosine on dementia.
With regard to Parkinson’s disease, some preliminary animal studies suggest that carnosinen could have neuroprotective effects and could help protect brain cells from the damage associated with the disease. However, clinical studies in humans are limited and more evidence is needed to better understand the effects of carnosine on Parkinson’s disease.
In terms of Alzheimer’s disease, research has focused on carnosine as a potential means of reducingreduce the formation of beta-amyloid plaques and tau protein tangles that are associated with the disease. Preliminary animal studies suggest that carnosine may have a protective effect on brain cells and may help reduce neurodegeneration associated with Alzheimer’s disease. However, further research is needed to confirm these effects in humans.
https:// www.carnomed.sk/produkty/karnozin-extra.htm
https:// www.carnomed.sk/produkty/karnozin-extra-pure-and-strong.htm
https:// www.carnomed.sk/produkty/karnozin-extra-60.htm
https:// www.karnozin.sk
https:// www.karnozin.sk/neuroprotektant